Cargando…
Neuroprotective effect of engineered Clostridium butyricum‐pMTL007‐GLP‐1 on Parkinson's disease mice models via promoting mitophagy
Parkinson's disease (PD) is a common neurodegenerative disease with limited treatment and no cure, hence, broadening PD drug spectrum is of great significance. At present, engineered microorganisms are attracting increasing attention. In this study, we constructed an engineered strain of Clostr...
Autores principales: | Wang, Yun, Chen, Wen‐jie, Han, Yi‐yang, Xu, Xuan, Yang, Ai‐xia, Wei, Jing, Hong, Dao‐jun, Fang, Xin, Chen, Ting‐tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189449/ https://www.ncbi.nlm.nih.gov/pubmed/37206220 http://dx.doi.org/10.1002/btm2.10505 |
Ejemplares similares
-
Engineered probiotics Clostridium butyricum‐pMTL007‐GLP‐1 improves blood pressure via producing GLP‐1 and modulating gut microbiota in spontaneous hypertension rat models
por: Wang, Xin‐liang, et al.
Publicado: (2022) -
The pMTL70000 modular, plasmid vector series for strain engineering in Cupriavidus necator H16
por: Ehsaan, Muhammad, et al.
Publicado: (2021) -
Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate
por: Liu, Jiaming, et al.
Publicado: (2015) -
Biotechnological potential of Clostridium butyricum bacteria
por: Szymanowska-Powałowska, Daria, et al.
Publicado: (2014) -
Effect of Clostridium butyricum on Gastrointestinal Infections
por: Ariyoshi, Tadashi, et al.
Publicado: (2022)